Real Chemistry Appoints Andy Johnson as Chief Information Officer

SAN FRANCISCO--(BUSINESS WIRE)--Real Chemistry, a leading provider of data-driven, tech-enabled communication and marketing solutions for the health care sector, today announced that Andy Johnson has joined the company as Chief Information Officer (CIO). Johnson’s primary responsibilities will be to drive Real Chemistry’s information strategy, strengthen organizational systems and processes to best support the company’s people and clients, and innovate new ways to connect and collaborate.

“Real Chemistry has been a pioneer of technology, data and analytics in our industry for decades, and I look forward to building on this strong foundation to make us an even better organization for our people, clients and the patients we ultimately serve,” said Johnson. “It’s a privilege to join a purpose-driven company that is also poised for continued growth and scale. I am eager to help take us to the next level.”

Johnson comes to Real Chemistry from Wunderman Thompson, a WPP company, where he served as CIO and previously held various IT leadership roles throughout the WPP network over the last 10 years. Prior to WPP, Johnson worked in the software industry, holding roles in development, product management and consulting throughout Europe.

“We are excited and fortunate to bring in a leader with Andy’s deep experience in information technology specific to the marketing and communications industry,” said Real Chemistry CEO Shankar Narayanan. “Andy has a proven track record of leading IT functions at large organizations in our industry and will be instrumental in scaling, simplifying and further digitizing the way we work. Leadership and innovation in these areas has never been more important.”

About Real Chemistry

Real Chemistry is making the world a healthier place by empowering patients to access the right treatment at the right time. We leverage the best data-driven, tech-enabled and digital solutions to deliver communications, engagement, activation and value across a full range of diverse health care stakeholders — patients, payors, providers, caregivers and regulators.

Our patient-centric approach pairs owned and partnered real-world data sources and proprietary technologies with analytical insights and modern marketing and communications services to solve today’s biggest engagement and commercialization challenges, including diversifying and speeding clinical trial awareness and enrollment, expanding product lifecycles and shortening the revenue curve. From finding patients with complicated or rare diseases to participate in clinical trials to targeting omnichannel marketing efforts to exactly the right audience, Real Chemistry is advancing transformation at the intersection of consumerization, personalization and digitization impacting health care today.

For more information, please visit www.realchemistry.com and connect with us on Twitter and LinkedIn.